Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  New England Journal of Medicine

• Publication date

  2011-08-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa1013068PMID 21848462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics.

  2011cited by this paper
• An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist

  2011cited by this paper
• The IL-1 family: regulators of immunity

  2010cited by this paper
• IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis

  2010cited by this paper
• A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1

  2010cited by this paper
• Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals.

  2010cited by this paper
• IL-1 family nomenclature

  2010cited by this paper
• Interleukin-1beta and the autoinflammatory diseases.

  2009cited by this paper
• An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

  2009cited by this paper
• Immunological and inflammatory functions of the interleukin-1 family.

  2009cited by this paper
• An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

  2009cited by this paper
• Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways

  2008cited by this paper
• A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci

  2008cited by this paper
• Pathogenesis and therapy of psoriasis

  2007cited by this paper
• Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

  2007cited by this paper
• The clinical spectrum of psoriasis.

  2007cited by this paper
• Pathogenesis and clinical features of psoriasis.

  2007cited by this paper
• Generalized pustular psoriasis (Zumbusch): a French epidemiological survey.

  2006cited by this paper
• Estimating the age of rare disease mutations: the example of Triple-A syndrome

  2004cited by this paper
• Inherited disorders of NF-κB-mediated immunity in man

  2004cited by this paper
• Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-κB and MAPKs*

  2004cited by this paper
• Inherited disorders of NF-kappaB-mediated immunity in man.

  2004cited by this paper
• Impetigo herpetiformis followed by generalized pustular psoriasis: more evidence of same disease entity.

  2003cited by this paper
• Generalized pustular psoriasis: strategy for identification of psoriasis susceptibility gene

  2003cited by this paper
• Pathophysiology of generalized pustular psoriasis

  2003cited by this paper
• Anaphylaxis due to burdock

  2003cited by this paper
• High-resolution structure of murine interleukin 1 homologue IL-1F5 reveals unique loop conformations for receptor binding specificity.

  2003cited by this paper
• Genomic organization of the interleukin-1 locus.

  2002cited by this paper
• Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2.

  2001cited by this paper
• Two Novel IL-1 Family Members, IL-1δ and IL-1ε, Function as an Antagonist and Agonist of NF-κB Activation Through the Orphan IL-1 Receptor-Related Protein 21

  2001cited by this paper
• Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family*

  2000cited by this paper
• Four New Members Expand the Interleukin-1 Superfamily*

  2000cited by this paper
• A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation

  1999cited by this paper
• Juvenile generalized pustular psoriasis in a pair of monozygotic twins presenting strikingly similar clinical courses.

  1992cited by this paper
• Generalized pustular psoriasis. A review of 63 cases.

  1991cited by this paper
• Familial juvenile generalized pustular psoriasis.

  1984cited by this paper
• Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases.

  1968cited by this paper

• Generalized pustular psoriasis induced by an intraductal pancreatic tumour producing IL-36γ: A case report.

  2026cites this paper
• Integrated human and mouse single-cell profiling reveals immune-stromal niche driving silicosis.

  2026cites this paper
• Reprogramming immunity at the metabolic-epidermal interface in obesity-associated psoriasis.

  2026cites this paper
• Psoriasis in children with dark skin phototypes: Epidemiological and clinical profile in Ouagadougou, Burkina Faso

  2026cites this paper
• Reply.

  2026cites this paper
• Interleukin-36 receptor antagonist deficiency patient with a novel mutation.

  2026cites this paper
• A unique combination of Generalised Pustular Psoriasis (GPP), Acrodermatitis Continua of Hallopeau (ACH), and psoriatic arthritis (both axial and peripheral) in a young male – a case-based review of literature

  2026cites this paper
• The IL-36 cytokine family: From barrier immunity to therapeutic target in inflammatory diseases.

  2026cites this paper
• Dupilumab-induced Psoriasis

  2025cites this paper
• Skin immune microenvironment in psoriasis: from bench to bedside

  2025cites this paper
• Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy.

  2025cites this paper
• Whole-genome sequencing reveals rare and structural variants contributing to psoriasis and identifies CERCAM as a risk gene

  2025cites this paper
• Clinical Features and Long-Term Outcomes in 109 Pediatric Generalized Pustular Psoriasis

  2025cites this paper
• Relationship between time-dependent epidermal ceramide composition changes and skin barrier function in adult mice.

  2025cites this paper
• Endothelial IL-36 receptor activation promotes vascular stability to limit pathological microvessel permeability in the CNS

  2025cites this paper
• Generalized Pustular Psoriasis.

  2025cites this paper
• LL37 complexed to double-stranded RNA induces RIG-I-like receptor signalling and Gasdermin E activation facilitating IL-36γ release from keratinocytes

  2025cites this paper
• Abrocitinib Treatment for Localized Type of Generalized Pustular Psoriasis: A Case Report

  2025cites this paper
• Quality of life of patients with pustular psoriasis is inferior to that of patients with plaque psoriasis in Japan: A multicenter study with questionnaires, the short Form‐36, and other patient‐reported outcomes

  2025cites this paper
• Current status of generalized pustular psoriasis: Findings from a multicenter hospital-based survey of 127 Chinese patients

  2025cites this paper
• Acrodermatitis Continua of Hallopeau - clinical review and proposed management algorithm.

  2025cites this paper
• IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations

  2025influential citation
• From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP

  2025cites this paper
• The Genetics of Acne

  2025cites this paper
• A receptor antagonist counterbalances multiple systemin phytocytokines in tomato.

  2025cites this paper
• Decoding Immunobiology Through Genetic Errors of Immunity.

  2025cites this paper
• Clinical characteristics, disease burden, and unmet medical needs of generalized pustular psoriasis: Results of the SCRIPTOR study.

  2025cites this paper
• Generalized pustular psoriasis: Advances in pathogenesis, diagnosis, and treatment.

  2025cites this paper
• IL-1 family cytokines in inflammation and immunity

  2025influential citation
• Clinical characteristics, treatment outcomes, and relapse prediction in 199 patients with generalized pustular psoriasis: a retrospective cohort study

  2025cites this paper
• Efficacy and safety of spesolimab in the treatment of generalized pustular psoriasis in elderly patients.

  2025cites this paper
• Acrodermatitis continua of Hallopeau successfully treated with spesolimab.

  2025cites this paper
• The Role of IL-17 in Systemic Autoinflammatory Diseases: Mechanisms and Therapeutic Perspectives

  2025cites this paper
• Treating Generalized Pustular Psoriasis (GPP): Timing and Rationale for Biologic Treatment Switching—A Japanese e-Delphi Survey

  2025cites this paper
• Intralesional Spesolimab: A Novel and Effective Approach for Palmoplantar Pustulosis Treatment – A Case Report

  2025cites this paper
• Structural basis of pro-inflammatory signaling via the Interleukin-36 receptor (IL-36R) mediated by IL-36γ and IL-37

  2025cites this paper
• Differentiating the Role of Inflammation in Hidradenitis Suppurativa from that in Other Inflammatory Skin Diseases.

  2025cites this paper
• Generalized Pustular Psoriasis Brazilian Experts Survey: Challenges in Disease Management

  2025cites this paper
• Generalized pustular psoriasis (von Zumbusch) flares successfully treated with Spesolimab. Report of two cases and review of the literature

  2025cites this paper
• What is ‘chronic’ pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment

  2025cites this paper
• IL-36RN gene: key insights into its role in pediatric pustular psoriasis pathogenesis and treatment

  2025cites this paper
• Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis

  2025influential citation
• When should a neonatologist consult a rheumatologist?

  2025cites this paper
• Spesolimab in generalized pustular psoriasis complicated by acrodermatitis continua of Hallopeau: a case report and mechanistic insights

  2025cites this paper
• Diseases of the interleukin-36 pathway.

  2025cites this paper
• Epidemiological, Genetic, Clinical, and Treatment Differences of Generalized Pustular Psoriasis and Acrodermatitis Continua of Hallopeau Across Ethnicities: A Systematic Review

  2025cites this paper
• Dynamic neutrophil-keratinocyte communication network centered on IL-36/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis

  2025cites this paper
• Crises de psoríase pustulosa generalizada (von Zumbusch) tratadas com sucesso com espesolimabe. Relato de dois casos e revisão da literatura

  2025cites this paper
• Decoding Non-Coding RNA Regulators in DITRA: From Genomic Insights to Potential Biomarkers and Therapeutic Targets

  2025influential citation
• Epicutaneous Staphylococcus aureus initiates cross-tissue IL-36R signaling for neutrophilic lung inflammation in a model of the atopic march

  2025cites this paper
• Literature review and expert opinion on diagnosis and current management of generalized pustular psoriasis

  2025cites this paper
• Spesolimab Treatment in GPP: Impact of IL-36RN Mutations and Concomitant Plaque Psoriasis

  2025cites this paper
• Ivermectin decreases inflammation and imiquimod–induced psoriasis-like skin lesions in rat via targeting TLR4/p65 NF-κB

  2025cites this paper
• IL-36-driven pustulosis: Transcriptomic signatures match between generalized pustular psoriasis (GPP) and acute generalized exanthematous pustulosis (AGEP).

  2025cites this paper
• NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasis

  2025cites this paper
• Successful Treatment of Generalized Pustular Psoriasis With Spesolimab in Two Young Children.

  2025cites this paper
• Single‐cell transcriptomic analysis of GPP patients treated with IL‐12/23 or IL‐17A blockade

  2025cites this paper
• Human inborn errors of type I interferon-independent intrinsic immunity in nonleukocytic cells.

  2025cites this paper
• The Role of Crosstalk between Nets and Keratinocytes in Skin Immunity.

  2025cites this paper
• Spesolimab for generalized pustular psoriasis: a review of two key clinical trials supporting initial US regulatory approval

  2024cites this paper
• Successful treatment with spesolimab for generalized pustular psoriasis in an elderly patient with TRPM4 mutation

  2024cites this paper
• Real-world use of spesolimab for the treatment of generalized pustular psoriasis: reports from four cases

  2024cites this paper
• Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterisation of Flare Treatment in EFFISAYIL® 1.

  2024cites this paper
• New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors

  2024cites this paper
• Considerations for defining and diagnosing generalized pustular psoriasis

  2024influential citation
• Functional Genomics in Psoriasis

  2024cites this paper
• Potential of Cyclosporine in the Treatment of Psoriasis: Trends, Scope and Relevance Providing Newer Insights Into Immune Mechanisms

  2024cites this paper
• Generalized Pustular Psoriasis and Systemic Organ Dysfunctions

  2024cites this paper
• Molecular aspects of Interleukin-36 cytokine activation and regulation.

  2024cites this paper
• Management of Pustular Psoriasis; The Way Ahead

  2024cites this paper
• Autoantibody mediated Deficiency of IL-36-Receptor antagonist in a subset of patients with Psoriasis and Psoriatic Arthritis.

  2024cites this paper
• Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.

  2024cites this paper
• Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study.

  2024cites this paper
• Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling

  2024cites this paper
• International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.

  2024cites this paper
• Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report

  2024influential citation
• The role of interleukin‐36 in health and disease states

  2024influential citation
• Genetic and epigenetic dysregulation of innate immune mechanisms in autoinflammatory diseases

  2024cites this paper
• Generalized Pustular Psoriasis, Acute Generalized Exanthematous Pustulosis, and Other Pustular Reactions: A Clinical Review.

  2024cites this paper
• Inflammasomes in epithelial innate immunity: front line warriors

  2024cites this paper
• Inflammatory loop involving Staphylococcus aureus, IL-36γ, and cathepsin S drives immunity disorders in familial acne inversa keratinocytes

  2024cites this paper
• Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report

  2024cites this paper
• Sclerosing cholangitis exacerbated by widespread pustular psoriasis

  2024cites this paper
• IL-36 Regulates Neutrophil Chemotaxis and Bone Loss at the Oral Barrier

  2024cites this paper
• Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26

  2024cites this paper
• Targeted review of IL36RN mutations in patients with generalised pustular psoriasis

  2024cites this paper
• Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments

  2024cites this paper
• Characteristics and management of generalized pustular psoriasis (GPP): Experience from the Central and Eastern Europe (CEE) GPP Expert Network

  2024influential citation
• Neutrophil IL-26 fuels autoinflammation

  2024cites this paper
• Severe flare of generalized pustular psoriasis treated with spesolimab, an IL‐36‐directed monoclonal antibody

  2024cites this paper
• Pediatric Neutrophilic Dermatoses.

  2024cites this paper
• Regional differences in the prevalence of generalized pustular psoriasis in Japan

  2024influential citation
• A fluorescence imaging technique suggests that sweat leakage in the epidermis contributes to the pathomechanism of palmoplantar pustulosis

  2024cites this paper
• Clinical Characteristics, Treatment, and Prognosis of Amoxicillin-Induced AGEP/ALEP

  2024cites this paper
• Human genetic errors of immunity illuminate an adaptive arsenal model of rapid defenses.

  2024cites this paper
• Interleukins and Psoriasis

  2024cites this paper
• Generalized pustular psoriasis: immunological mechanisms, genetics, and emerging therapeutics.

  2024cites this paper
• Updated genetic background of generalized pustular psoriasis as an autoinflammatory keratinization disease

  2024cites this paper
• Parental Consanguinity and Family History in Relation to Psoriasis and the Role of Sex: A Case-Control Study

  2024cites this paper
• The riddle of recurrent fever: a clinical approach to pediatric autoinflammatory diseases

  2024cites this paper